Now Offering Allergy Drops (SLIT) – A Convenient At-Home Allergy Treatment!
Learn how Sublingual Immunotherapy can help relieve your allergy symptoms. Learn More or Schedule an Appointment

Online Bill Pay
Patient Portal

Neuromark

NEUROMARK is an innovative, clinically proven procedure designed to safely target the root cause of chronic rhinitis—overactive posterior nasal nerves (PNN). By using low-power energy to disrupt these nerves, NEUROMARK may provide durable relief from persistent symptoms.

What are the benefits?

Safe and Effective³
NEUROMARK has been clinically tested to ensure it meets the highest safety standards while delivering effective results.³

Minimally Invasive
NEUROMARK is gentle, minimally invasive, and typically comes with no downtime, allowing patients to return to their regular day.

Targets the Source
Instead of just managing symptoms, NEUROMARK addresses the overactive PNNs that cause CR.

Precise Treatment
NEUROMARK’s flexible shaft and atraumatic leaflets conform to patient anatomy, maximizing access to nerve-rich areas and allowing for posterior placement.⁴ The narrow, malleable shaft enables the physician to shape the device to achieve access, even in challenging anatomy.

Real-Time Feedback
Confirm energy delivery with NEUROMARK’s apposition confirmation-guided leaflet placement with real-time visual feedback to help ensure proper apposition prior to energy delivery.⁴

Performance
NEUROMARK delivers clinically proven results that allow you to treat a broad range of CR patients with confidence. This includes durable, significant improvement in CR symptoms as well as excellent patient tolerability and safety.³,⁴

The TNSS, or Total Nose Symptom Score, is a tool used to assess the severity of nasal symptoms in individuals with chronic rhinitis. It asks just four questions to assess the impact of your symptoms on your quality of life.

Take the questionnaire below.

TNSS Questionnaire

References:

  • Vandenplas O, Vinnikov D, Blanc PD, et al. Impact of Rhinitis on Work Productivi.: A Systematic Review. J Allergy Clin Immunol Pract. 2018;6(4):1274-1286.e9. doi:10.1016/j.jaip.2017.09.002.
  • Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol. 2007;19:23-34.
  • Reh DD, Lay K, Davis G, et al. Long-term outcomes follow ing impedance-controlled radiofrequency ablation for the treatment of chronic rhinitis. Laryngoscope Investig Otolaryngol. 2024;9(3):e1286. Published 2024 Jun 4. doi:10.1002/lio2.1286.
  • Reh, DD, Lay KL, Davis G, et al. Clinical evaluation of a novel multipoint radiofrequency ablation device to treat chronic rhinitis. Laryngoscope Investig Otolaryngol. 2023. Published online 16 March 2023:DOI: 10.1002/lio2.1040.